Skip to content
Products search
Journey of Innovation
Products search
Journey of Innovation
Home
About Us
Products
Process Development
Facility
Gallery
Contact Us
Home
About Us
Products
Process Development
Facility
Gallery
Contact Us
Showing 657–672 of 1401 results
Default sorting
Sort by popularity
Sort by average rating
Sort by latest
Sort by price: low to high
Sort by price: high to low
ELVITEGRAVIR KSM-I
CAS NO.
28314-83-2
Mol. W.
236.99
Mol. F.
C7H2BrF2O2
Enquire Now
Elvitegravir KSM-II Impurity-K2G
CAS NO.
7533-40-6
Mol. W.
117.18
Mol. F.
C6H15NO
Enquire Now
ELVITEGRAVIR KSM-III
CAS NO.
85070-47-9
Mol. W.
223.47
Mol. F.
C7H5BrClF
Enquire Now
ELVITEGRAVIR KSM-III_IMPURITY-K3A
CAS NO.
85070-48-0
Mol. W.
158.56
Mol. F.
C7H4ClFO
Enquire Now
ELVITEGRAVIR KSM-III_IMPURITY-K3D
CAS NO.
446-48-0
Mol. W.
189.02
Mol. F.
C7H6BrF
Enquire Now
Empagliflozin hydroxy Impurity
CAS NO.
2137418-13-2
Mol. W.
466.90
Mol. F.
C23H27ClO8
Enquire Now
Empagliflozin Impurity-II
CAS NO.
NA
Mol. W.
288.76
Mol. F.
C17H17ClO2
Enquire Now
Empagliflozin Impurity-IV (S-III-Methoxy)
CAS NO.
915095-96-4
Mol. W.
480.93
Mol. F.
C24H29ClO8
Enquire Now
Empagliflozin ST-II
CAS NO.
915095-90-8
Mol. W.
367.67
Mol. F.
C17H16BrClO2
Enquire Now
Empagliflozin std
CAS NO.
864070-44-0
Mol. W.
450.90
Mol. F.
C23H27ClO7
Enquire Now
Enantiomer of Letermovir
CAS NO.
917389-37-8
Mol. W.
572.55
Mol. F.
C29H28F4N4O4
Enquire Now
Endo unreduced isomer Lurasidone KSM-III
CAS NO.
129-64-6
Mol. W.
164.15
Mol. F.
C9H8O3
Enquire Now
Entacapone Related comp-B
CAS NO.
1215039-66-9
Mol. W.
278.22
Mol. F.
C12H10N2O6
Enquire Now
Entacapone Related comp-C
CAS NO.
116313-85-0
Mol. W.
183.11
Mol. F.
C7H5NO5
Enquire Now
Entacapone Related comp-D
Mol. W.
333.33
Mol. F.
C16H19N3O5
Enquire Now
Epinaphrine methyl analog
CAS NO.
2947-02-6
Mol. W.
197.23
Mol. F.
C10H15NO3
Enquire Now
←
1
2
3
…
39
40
41
42
43
44
45
…
86
87
88
→
Home
About Us
Products
Process Development
Facility
Gallery
Contact Us
Home
About Us
Products
Process Development
Facility
Gallery
Contact Us
Facebook-f
Instagram
Linkedin-in
X-twitter